跳至主要内容
临床试验/NCT04251572
NCT04251572Unknown不适用

Hepatitis C Reinfection After Successful Directly Acting Antiviral Treatment: A Belgian Interventional Multicenter Study

Hasselt University20 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
20
主要终点
Number of reinfections in people who inject drugs after cure for hepatitis C infection with direct antiviral therapy

研究概览

简要总结

The primary aim of this study is to calculate the incidence of HCV reinfection after successful DAA treatment among people who have recently injected drugs. The secondary aim is to identify factors associated with reinfection in this population.

Individuals with active injecting drug abuse with a chronic HCV infection who have achieved end of treatment response (ETR; defined as non-detectable HCV RNA at end of treatment) to any interferon-free DAA combination will be included in this multicenter interventional study.

详细描述

This protocol is an adapted version of the protocol 'Hepatitis C reinfection after successful directly acting antiviral treatment: A North-Atlantic multicenter interventional study'. The investigators will plan this study so that the data are similar to this protocol and results can be compared within this alliance of hepatologists with special interest in care for substance users.

Study schedule: Data collection will be performed according to the study schedule shown in Table 1. Following assessment for SVR12, participants will be followed for 2 years at 6 months' intervals at the discretion of each study site.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent
  • Age 18 years or older
  • Injecting drug use within 6 months before start of treatment
  • Achieved an ETR following at least eight weeks of DAA treatment
  • Completed DAA treatment no more than 6 months prior to inclusion
  • Blood sample drawn within 6 months pre-treatment stored at -70° C

排除标准

  • Patients not fulfilling the inclusion criteria.

结局指标

主要结局

Number of reinfections in people who inject drugs after cure for hepatitis C infection with direct antiviral therapy

时间窗: up to two years

Number of reinfections with hepatitis C per 100 persons

次要结局

  • questionaire to Identify risk factors associated with HCV reinfection(up to 2 years)
  • questionnaire to Identify risk factors associated with HCV reinfection(day 1)

研究者

发起方
Hasselt University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Geert Robaeys

Principal Investigator

Hasselt University

研究点 (20)

Loading locations...

相似试验